Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC)

Heavily indebted poor countries (HIPC): Access to anti-retroviral drugs, male was 80.4% in 2024. ◆ Volatile

Latest (2024)
80.4%
Change on year
up 5.3%
Rank
6th
of 19 groups
All-time high
80.4%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC), 2000–2024

0204060802000201220242000: 0 %2001: 0.119 %2002: 0.123 %2003: 0.451 %2004: 1.9 %2005: 3.9 %2006: 6.5 %2007: 10.7 %2008: 14.5 %2009: 18.4 %2010: 21.5 %2011: 24.8 %2012: 27.9 %2013: 31.5 %2014: 36 %2015: 39.9 %2016: 44.5 %2017: 50.5 %2018: 54.3 %2019: 59.4 %2020: 64.6 %2021: 68.4 %2022: 73 %2023: 76.3 %2024: 80.4 %

Source: UNAIDS estimates. Measured in %.

Analysis

In 2024, access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC) stood at 80.4%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 5.3% on the previous year and up 123.3% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC) peaked at 80.4% in 2024 and was at its lowest, 0.0%, in 2000.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC), year by year

Annual values for Access to anti-retroviral drugs, male (%) in Heavily indebted poor countries (HIPC), 2000 to 2024.
Year % Change
2000 0.0%
2001 0.1%
2002 0.1% +3.5%
2003 0.5% +265.1%
2004 1.9% +321.0%
2005 3.9% +106.7%
2006 6.5% +66.4%
2007 10.7% +63.4%
2008 14.5% +36.0%
2009 18.4% +26.6%
2010 21.5% +16.8%
2011 24.8% +15.7%
2012 27.9% +12.2%
2013 31.5% +13.2%
2014 36.0% +14.1%
2015 39.9% +10.8%
2016 44.5% +11.6%
2017 50.5% +13.4%
2018 54.3% +7.5%
2019 59.4% +9.4%
2020 64.6% +8.8%
2021 68.4% +5.8%
2022 73.0% +6.8%
2023 76.3% +4.6%
2024 80.4% +5.3%

Biggest year-on-year movements

Years where Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2004 +321.0% 0.5% 1.9%
2003 +265.1% 0.1% 0.5%
2005 +106.7% 1.9% 3.9%

Averages by decade

DecadeAverage LowestHighest Years
2000s 5.7% 0.0% 18.4% 10
2010s 39.0% 21.5% 59.4% 10
2020s 72.5% 64.6% 80.4% 5

Countries ranked near Heavily indebted poor countries (HIPC)

  1. 3 Cambodia 96.0% compare
  2. 4 Rwanda 95.0% compare
  3. 4 Sweden 95.0% compare
  4. 4 Zambia 95.0% compare
  5. 7 Denmark 93.0% compare
  6. 7 Ethiopia 93.0% compare
  7. 7 Saudi Arabia 93.0% compare
  8. 7 United Kingdom of Great Britain and Northern Ireland 93.0% compare

See the full ranking of 160 places →

More gender data for Heavily indebted poor countries (HIPC)

All data for Heavily indebted poor countries (HIPC) →

Frequently asked questions

What is access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC)?
Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC) was 80.4% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Heavily indebted poor countries (HIPC)?
The highest recorded value was 80.4% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Heavily indebted poor countries (HIPC)?
The lowest recorded value was 0.0% in 2000.
How does Heavily indebted poor countries (HIPC) rank for access to anti-retroviral drugs, male?
Heavily indebted poor countries (HIPC) ranks 6th out of 19 groups with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Heavily indebted poor countries (HIPC)?
Over the last ten years it is up 123.3%. The long-run trend across the full record is volatile.
Where does this Heavily indebted poor countries (HIPC) data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC). Statizoid, drawing on UNAIDS estimates. Retrieved 14 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/heavily-indebted-poor-countries-hipc/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/heavily-indebted-poor-countries-hipc/">Access to anti-retroviral drugs, male in Heavily indebted poor countries (HIPC)</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.